Clearmind Medicine Investor Relations Material

Clearmind Medicine Inc is a Canada-based biotechnology company focused on the research and development of psychedelic-derived therapeutics for the treatment of mental health conditions. The company is developing proprietary compounds aimed at addressing issues such as alcohol use disorder, depression, and anxiety. Clearmind’s approach combines psychedelic science with pharmaceutical development to create regulated treatment options. The company is headquartered in Vancouver, British Columbia, and its shares are listed on the CSE.